0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Androgen Deprivation Therapy (ADT) Market Size, Status and Forecast 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-26T976
Home | Market Reports | Health | Medical Devices & Equipment
Global Androgen Deprivation Therapy ADT Market Size Status and Forecast 2021 2027

Global Androgen Deprivation Therapy (ADT) Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-26T976
Report
July 2021
107 Pages
QYResearch
Region: Global, North America, Europe, Japan,
Description
Table of Content
Tables & Figures
Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.
Market Analysis and Insights: Global Androgen Deprivation Therapy (ADT) Market

The global Androgen Deprivation Therapy (ADT) market size is projected to reach US$ 8369.7 million by 2027, from US$ 5773.1 million in 2020, at a CAGR of 5.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Androgen Deprivation Therapy (ADT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Androgen Deprivation Therapy (ADT) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Androgen Deprivation Therapy (ADT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Androgen Deprivation Therapy (ADT) market.
Global Androgen Deprivation Therapy (ADT) Scope and Market Size
Androgen Deprivation Therapy (ADT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Androgen Deprivation Therapy (ADT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Medicine
Surgery
Other

Segment by Application

Hospital
Clinic
Other

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2016-2027)
2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Regions
2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Share by Regions (2016-2021)
2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Regions (2022-2027)
2.3 Androgen Deprivation Therapy (ADT) Industry Dynamic
2.3.1 Androgen Deprivation Therapy (ADT) Market Trends
2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue
3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2016-2021)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2016-2021)
3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue
3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2020
3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served
3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2016-2021)
4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2022-2027)
5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2016-2021)
5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type
6.2.1 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
6.2.2 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
6.2.3 North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application
6.3.1 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
6.3.2 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
6.3.3 North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country
6.4.1 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
6.4.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type
7.2.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
7.2.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
7.2.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application
7.3.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
7.3.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
7.3.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country
7.4.1 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
7.4.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type
8.2.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application
8.3.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region
8.4.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
9.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type
9.2.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
9.2.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
9.2.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application
9.3.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
9.3.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
9.3.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country
9.4.1 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
9.4.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2016-2027)
10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type
10.2.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2027)
10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application
10.3.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2027)
10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country
10.4.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.2.5 Astellas Pharma Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis International
11.4.1 Novartis International Company Details
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.4.5 Novartis International Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Veru
11.6.1 Veru Company Details
11.6.2 Veru Business Overview
11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.6.5 Veru Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Orion
11.10.1 Orion Company Details
11.10.2 Orion Business Overview
11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.10.5 Orion Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021)
11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Medicine
    Table 3. Key Players of Surgery
    Table 4. Key Players of Other
    Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2016-2021)
    Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2022-2027)
    Table 11. Androgen Deprivation Therapy (ADT) Market Trends
    Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
    Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
    Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
    Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players (2016-2021)
    Table 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2020)
    Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
    Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2016-2021)
    Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Androgen Deprivation Therapy (ADT) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2016-2021)
    Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
    Table 37. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
    Table 38. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
    Table 43. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
    Table 44. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2016-2021) & (US$ Million)
    Table 49. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2022-2027) & (US$ Million)
    Table 50. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
    Table 55. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
    Table 56. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2016-2021) & (US$ Million)
    Table 61. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2022-2027) & (US$ Million)
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Androgen Deprivation Therapy (ADT) Product
    Table 65. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 66. Pfizer Recent Development
    Table 67. Astellas Pharma Company Details
    Table 68. Astellas Pharma Business Overview
    Table 69. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
    Table 70. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 71. Astellas Pharma Recent Development
    Table 72. Johnson & Johnson Company Details
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
    Table 75. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 76. Johnson & Johnson Recent Development
    Table 77. Novartis International Company Details
    Table 78. Novartis International Business Overview
    Table 79. Novartis International Androgen Deprivation Therapy (ADT) Product
    Table 80. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 81. Novartis International Recent Development
    Table 82. Merck Company Details
    Table 83. Merck Business Overview
    Table 84. Merck Androgen Deprivation Therapy (ADT) Product
    Table 85. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 86. Merck Recent Development
    Table 87. Veru Company Details
    Table 88. Veru Business Overview
    Table 89. Veru Androgen Deprivation Therapy (ADT) Product
    Table 90. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 91. Veru Recent Development
    Table 92. Sanofi Company Details
    Table 93. Sanofi Business Overview
    Table 94. Sanofi Androgen Deprivation Therapy (ADT) Product
    Table 95. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 96. Sanofi Recent Development
    Table 97. GlaxoSmithKline Company Details
    Table 98. GlaxoSmithKline Business Overview
    Table 99. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 100. GlaxoSmithKline Recent Development
    Table 101. Bayer Company Details
    Table 102. Bayer Business Overview
    Table 103. Bayer Androgen Deprivation Therapy (ADT) Product
    Table 104. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 105. Bayer Recent Development
    Table 106. Orion Company Details
    Table 107. Orion Business Overview
    Table 108. Orion Androgen Deprivation Therapy (ADT) Product
    Table 109. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 110. Orion Recent Development
    Table 111. AstraZeneca Company Details
    Table 112. AstraZeneca Business Overview
    Table 113. AstraZeneca Androgen Deprivation Therapy (ADT) Product
    Table 114. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2016-2021) & (US$ Million)
    Table 115. AstraZeneca Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2020 VS 2027
    Figure 2. Medicine Features
    Figure 3. Surgery Features
    Figure 4. Other Features
    Figure 5. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Other Case Studies
    Figure 9. Androgen Deprivation Therapy (ADT) Report Years Considered
    Figure 10. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Androgen Deprivation Therapy (ADT) Market Share by Regions: 2020 VS 2027
    Figure 13. Global Androgen Deprivation Therapy (ADT) Market Share by Regions (2022-2027)
    Figure 14. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2020
    Figure 15. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2020
    Figure 17. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2016-2021)
    Figure 18. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2022-2027)
    Figure 19. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
    Figure 21. North America Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
    Figure 22. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
    Figure 23. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
    Figure 27. Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
    Figure 28. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
    Figure 29. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Region (2016-2027)
    Figure 39. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
    Figure 47. Latin America Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
    Figure 48. Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
    Figure 49. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Country (2016-2027)
    Figure 55. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 59. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 61. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 62. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 63. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 64. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 66. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 67. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 68. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global and China IV Infusion Pump Accessories Market Insights Forecast to 2027
Global and China IV Infusion Pump Accessories Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34H6523
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and United States Wireless Patient Monitoring Devices Market Insights Forecast to 2027
Global and United States Wireless Patient Monitoring Devices Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-11P6875
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and China Hemostatic Valves Market Insights Forecast to 2027
Global and China Hemostatic Valves Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-13D6835
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global and United States Blood Glucose Device SMBG Market Insights Forecast to 2027
Global and United States Blood Glucose Device (SMBG) Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34D6519
Sun Sep 05 00:00:00 UTC 2021

Add to Cart